957121-34-5 Usage
Description
(R)-tert-butyl 2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridine]-5-ylcarbamate is a complex organic compound featuring a spirocyclic structure with an indene-pyrrolo-pyridine core. It is characterized by the presence of a tert-butyl protecting group and a trimethylsilyl ether moiety. As a carbamate derivative, it is an ester formed from carbonic acid and an organic amine, which positions it as a potential candidate in medicinal chemistry for the development of pharmaceuticals targeting specific biological pathways.
Uses
Used in Pharmaceutical Development:
(R)-tert-butyl 2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridine]-5-ylcarbamate is used as a potential pharmaceutical agent for targeting specific biological pathways. Its unique structure and functional groups may allow it to interact with biological targets, such as enzymes or receptors, which could be relevant for the treatment of various diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (R)-tert-butyl 2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridine]-5-ylcarbamate serves as a valuable compound for research purposes. Its synthesis and modification can provide insights into the design and development of new drugs with improved efficacy and selectivity.
Used in Drug Delivery Systems:
Similar to other complex organic compounds, (R)-tert-butyl 2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridine]-5-ylcarbamate may be utilized in the development of novel drug delivery systems. These systems could enhance the compound's bioavailability, delivery, and therapeutic outcomes by employing various organic and metallic nanoparticles as carriers.
Used in Chemical Synthesis:
(R)-tert-butyl 2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridine]-5-ylcarbamate may also find applications in chemical synthesis, where it can serve as a building block or intermediate for the creation of more complex molecules with diverse biological activities. Its unique structural features could be exploited to synthesize new compounds with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 957121-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,1,2 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 957121-34:
(8*9)+(7*5)+(6*7)+(5*1)+(4*2)+(3*1)+(2*3)+(1*4)=175
175 % 10 = 5
So 957121-34-5 is a valid CAS Registry Number.
957121-34-5Relevant articles and documents
IMIDAZOLINONE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 74, (2010/08/04)
The present invention is directed to imidazolinone derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical comp
CONSTRAINED SPIROCYCLIC COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 38, (2008/12/06)
Compounds of formula I: I (wherein variables A1, A2, A3, G1, G2, G3, J, m, n, p, R1, R2, R3, R4 and Y are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is inv
CGRP RECEPTOR ANTAGONISTS WITH TERTIARY AMIDE, SULFONAMIDE, CARBAMATE AND UREA END GROUPS
-
Page/Page column 96, (2008/12/08)
Compounds of formula I: (I) (wherein variables A, m, n, J, Re, Rf, R4, Ea, Eb, Ec, RPG and Y are as described herein) which are antagonists of CGRP receptors and which are useful
